What Is the Utility of KDIGO Criteria to Identify High-Risk Populations?
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference15 articles.
1. Trial quality in nephrology: how are we measuring up?;Palmer;Am J Kidney Dis,2011
2. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Int Suppl,2013
3. Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
4. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials;Inker;Am J Kidney Dis,2014
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 1. Executive summary;Am J Kidney Dis,2002
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Dopamine System: Insights between Kidney and Brain;Kidney and Blood Pressure Research;2022
2. Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk;The Journal of Clinical Hypertension;2021-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3